Equigerminal is a biotech (veterinary) startup with the goal to improve well-being, performance and health of horses, developing solutions with state of the art technology, with particular focus on IP development and lab testing solutions.

‍

ISTART I fund exited Equigerminal on a trade sale with its management team, in May 2016.